Skip to main content
NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%NVDA-2.15%AAPL+1.33%GOOGL-0.14%MSFT-0.19%AMZN-0.04%TSM-1.84%SPCX+1.81%AVGO-0.20%META-0.07%TSLA-0.22%SKHY-4.72%MU-3.43%BRK-B+0.06%LLY+0.60%JPM-0.43%AMD-2.31%WMT+0.81%V-0.29%XOM-0.46%ASMLa-2.21%JNJ+0.11%INTC-5.28%MA-0.24%0700.HK-1.94%ORCL-2.05%1398.HK+0.79%BAC-0.09%ABBV+0.77%CSCO-0.26%CVX-1.01%COST+0.14%LRCX-3.69%KO+1.14%CAT-0.70%AMAT-1.87%0005.HK-0.78%AP2d-1.11%UNH+0.33%DELL-3.31%HSBA.L-0.98%MS+0.02%PG+0.08%GE+0.44%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.20%HD-0.86%GS-0.13%0939.HK+1.66%NZDJPY-2.67%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.52%GBPJPY-1.47%CADJPY-1.45%EURJPY-1.43%EURNZD+1.28%NZDCAD-1.23%GBPNZD+1.22%NZDUSD-1.18%NZDCHF-1.02%USDNOK+0.96%EURNOK+0.88%CHFNOK+0.85%NOKJPY-0.75%AUDNZD+0.74%USDZAR+0.67%USDSEK+0.61%EURZAR+0.58%USDMXN+0.57%AUDDKK-0.56%AUDCAD-0.54%EURAUD+0.54%EURSEK+0.53%CHFSEK+0.49%GBPZAR+0.49%AUDSGD-0.48%GBPAUD+0.48%AUDUSD-0.45%GBPTRY+0.41%USDTHB+0.38%GBPHKD+0.32%AUDNOK+0.31%NZDSGD-0.29%GBPMXN-0.28%AUDCHF-0.28%USDPLN+0.27%EURCHF+0.24%CADCHF+0.21%GBPCHF+0.20%EURPLN+0.19%USDCHF+0.17%USDSGD+0.17%USDILS+0.16%USDTRY+0.11%EURHKD-0.10%NZDMXN+0.10%USDDKK+0.09%EURSGD+0.08%EURUSD+0.08%PLNJPY-0.06%USDCAD-0.06%GBPUSD+0.05%EURGBP+0.05%EURCZK-0.05%CHFSGD+0.05%SGDJPY+0.05%USDCOP-0.04%USDCNH+0.03%GBPCAD-0.03%EURCNH-0.03%EURCAD+0.02%GBPSGD-0.02%USDHKD0.00%EURDKK0.00%XPTUSD-4.05%HG1-4.03%GAGUSD-3.64%XAGUSD-3.64%UKOIL+1.91%COFFEE-1.84%USOIL+1.73%W1-0.92%COCOA-0.78%GAUUSD-0.64%XAUUSD-0.63%C1-0.56%BTCUSD-1.24%ETHUSD-1.02%USDTUSD-0.06%XRPUSD-1.98%SOLUSD-1.46%TRXUSDT0.00%ZECUSDT-5.46%DOGEUSD-2.43%XMRUSDT-1.64%LINKUSD-0.97%XLMUSD-1.58%BCHUSDT-9.07%LTCUSD-1.45%UNIUSD-3.79%HBARUSDT-1.63%TONUSD+24.88%SUIUSD-2.90%TAOUSDT-4.20%AAVEUSD-2.75%DOTUSDT-3.16%ICPUSDT-0.72%ONDOUSDT-2.53%WLDUSDT-2.43%ATOMUSDT-3.24%ARBUSDT+1.19%JUPUSDT-2.53%INJUSDT-3.51%STXUSDT-3.07%FETUSDT-2.98%TIAUSDT-0.34%PYTHUSDT-0.58%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-2.81%OPUSDT-3.00%IOTAUSDT-3.05%POLUSDT-6.22%AXSUSDT-2.25%FARTCOINUSDT-1.70%EOSUSDT-1.18%DYDXUSDT-0.88%ORDIUSDT-0.21%GALAUSDT-3.65%NOTUSDT-1.83%RONINUSDT-2.64%
RE

Revvity, Inc. (RVTY)

NYSE • Healthcare

$123.85
-$3.23 (-2.5%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$127.43
Previous Close$123.85
Day Range$121.2 - $127.43
Avg. Volume (3M)1.5M
Market Cap$13.8B
P/E Ratio59.0
52 Week Range
$81.22$133
Next EarningsIn 46 daysOct 26, 2026

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$729.6M100%
Gross Profitminus cost of goods$416.8M57%
Operating Incomeminus R&D and overhead$89.3M12%
Net Incomeminus taxes and the rest$51.8M7%

In plain terms: out of every $100 in revenue, Revvity, Inc. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.9B
Net Income (TTM)
$237.5M
EPS (TTM)
$2.1
ROA (TTM)
1.97%
Current Ratio
1.8
Dividend Yield
0.062%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+8.3%Q1 2026$1.7
+3.9%Q2 2026$1.06
+16.5%Q3 2026$1.41
Next

Oct 26

in 46 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +16.5%

Revvity beat on adjusted EPS in the second fiscal quarter of 2026, reporting on Aug. 4 based on preliminary results, as adjusted EPS of $1.41 topped the $1.21 estimate by 16.5%. Revenue rose about 1% to roughly $729.7 million, with operating income at about $89.3 million, operating margin near 12%, and gross margin around 57%; net income came to about $51.8 million, down about 6% from about $55.2 million a year earlier. The company generated operating cash flow of about $195.6 million, repurchased $16.0 million of stock, and paid $7.8 million in dividends. Consensus for the next period calls for EPS of $1.30.

View full earnings history

About Revvity, Inc.

Revvity, Inc. (NYSE: RVTY) develops diagnostic and life sciences tools, software, and services for healthcare and research markets worldwide. The company, which operates in medical diagnostics and research, generated $2.9 billion of revenue in FY2025. It sells across discovery, analytical, and testing workflows rather than through a single product line.

Name
Revvity, Inc.
CEO
Prahlad R. Singh
Website
www.revvity.com
Industry
Healthcare
Year Founded
1937
Employees
11,000

Today's Snapshot

AI-generated

Yesterday RVTY fell 2.5% to 123.85. Revvity agreed to buy Human Cell Design, a cell-model company.

Trading Volume

Above 10d avg 1.8M

1.8M

vs S&P 500 Today

Underperforming Market

-2.06%

Updated: September 10, 2026 at 12:14 UTC

RVTY Headlines

Healthcare stocks fall after weak US jobs data

March 6, 2026

3 min read
View All News

Technical Indicators

3 Buy3 Neutral2 Sell
RVTY carries a Buy rating with the market around 123.85 and a longer-term structure that remains constructive as medium- and long-term averages sit below price. ADX in the mid-to-high 20s signals a strengthening trend, while MACD is positive even though short-term momentum is slightly negative, creating mixed near-term signals. OBV is negative, indicating recent selling pressure, and volatility is moderate with ATR near four dollars. The classic pivot at 127.84 marks nearby resistance but does not erase the broader bullish alignment. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$104.75 - $126.87
    Buy
  • RSI (14)52.58
    Neutral
  • Stochastic %K (14, 3, 3)65.04
    Neutral
  • MACD Level (12, 26)3.67
    Neutral

Peers & Related Assets

GHGuardant Health, Inc.
$162.78+1.1%
SOLVSolventum Corporation
$90.03-0.1%
CRLCharles River Laboratories International, Inc.
$278.35-0.9%
ALGNAlign Technology, Inc.
$150.11-1.8%
ENSGThe Ensign Group, Inc.
$171.76+0.7%
QGENQiagen N.V.
$42.5+0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.